After two years of post-graduate studies at the Max Planck Institute for Biochemistry in Munich, Dr. Jaenisch set his sights on a postdoctoral position in the United States, and joined Arnold Levine at Princeton University to work
with tumor viruses in mammalian systems.
Not exact matches
The investigators report that trapping
virus - loaded stem cells in a gel and applying them to
tumors significantly improved survival in mice
with glioblastoma multiforme, the most common brain
tumor in human adults and also the most difficult to treat.
The
virus, redesigned using sophisticated protein engineering techniques, works:
With its shield and its adapter, these viral gene shuttles efficiently infected
tumor cells in laboratory animals.
«If we could load these
virus shells
with a different cargo, say a drug, and target it to a particular place in the body, such as a
tumor, it could then deliver the drug to just that specific location, making the drug more effective, or reducing side effects,» Lawrence said.
To bring the wrath of the immune system down on
tumors, researchers have tried shooting them up
with a variety of molecules and
viruses.
Dr. Cripe and his colleagues at The Ohio State University, the University of Pittsburgh School of Medicine and Cincinnati Children's Hospital Medical Center tested how well the oncolytic viral therapy — a cancer - killing form of the herpes simplex
virus, called oHSV — infected and killed
tumor cells in mice
with and without a healthy immune system.
A team led by neuroscientist Khalid Shah, MS, PhD, who recently demonstrated the value of stem cells loaded
with cancer - killing herpes
viruses, now has a way to genetically engineer stem cells so that they can produce and secrete
tumor - killing toxins.
As an additional safety feature, the researchers introduced two mutations that weakened the
virus's ability to combat the cell's defenses against infection, reasoning that the mutated
virus still would be able to grow in
tumor cells — which have a poor antiviral defense system — but would be eliminated quickly in healthy cells
with a robust antiviral response.
«Our results are the first to provide insight into ways of targeting multiple brain metastatic deposits
with stem - cell - loaded oncolytic
viruses that specifically kill dividing
tumor cells.»
The Genomics Facility also is working
with other teams studying mutations in bladder cancer
tumors; genetic mechanisms of sickle cell disease;
viruses in Lake Michigan; and many other projects.
With respect to biological applications, the group is focusing on how cellular heterogeneity and cell - to - cell communication drive ensemble - level decision - making in the immune system, with an emphasis on «two - body» interaction (e.g., host cell - virus interactions, innate immune control of adaptive immunity, tumor infiltration by immune cel
With respect to biological applications, the group is focusing on how cellular heterogeneity and cell - to - cell communication drive ensemble - level decision - making in the immune system,
with an emphasis on «two - body» interaction (e.g., host cell - virus interactions, innate immune control of adaptive immunity, tumor infiltration by immune cel
with an emphasis on «two - body» interaction (e.g., host cell -
virus interactions, innate immune control of adaptive immunity,
tumor infiltration by immune cells).
In collaboration
with Pedro Romero, Vincenzo Cerundolo and colleagues demonstrate that, unlike
virus - specific CTLs, the highest frequency of
tumor - specific CTLs can be found in
tumor - infiltrated lymph nodes.
Magnus Essand and Justyna Leja at SciLifeLab / Uppsala University has together
with their colleagues developed a new treatment for
tumors, using
viruses.
Early observations suggesting that the
virus might attack cancer in part by damaging blood vessels that feed
tumor growth led the SillaJen team to strike up a collaboration
with McDonald, an expert in
tumor vasculature, to investigate the
virus's mechanism of action in animal models.
In this case, they would target proteins associated
with the Epstein Barr
virus, which the
tumors would express.
Mice injected
with a strain of the Zika
virus lived longer and were measured to have smaller
tumors than the control group, which was injected
with saltwater.
JJ Miranda, PhD, reported that certain drugs affect genes in
tumor cells infected
with the Epstein - Barr
Virus.
Trautmann L, Labarrière N, Jotereau F, Karanikas V, Gervois N, Connerotte T, Coulie P, Bonneville M. Dominant TCR Va usage by
virus and
tumor reactive T cells
with wide affinity ranges for their specific antigens.
I am currently working
with Zika
virus and how it affects the T cell response and T cell signaling through
tumor necrosis receptor (TNFR) signaling components OX40, 4 - 1BB, and CD27 in specific mouse model systems.
Turnstone's therapeutic platform is a first - in - class,
tumor - targeted oncolytic vaccine that combines potent
tumor - killing effects of oncolytic
viruses with the benefits of a cancer vaccine that harnesses the patient's own immune system to fight disease in a sustainable manner.
Effector and target modules together form a novel platform which allows us to engage target cells (e.g.
tumor cells,
virus infected cells) directly
with immune effector cells.
The chronically stressed mice had decreased immune function and experienced
tumor development significantly earlier than the non-stressed mice.16 Other mouse studies of ovarian cancer showed that chronic stress resulted in increased cancer growth as well as increased angiogenesis, the process
with which cancer forms new blood vessels to feed itself nutrients for growth and metastases.17 Chronic stress has also been shown to decrease our body's ability to mount an attack against foreign invaders, including
viruses.18 As we know that several
viruses can cause cancer (HPV and cervical cancer, and EBV and nasopharyngeal cancer), we can extrapolate that any decrease in immune function could increase cancer risk.
Many
viruses, bacteria, parasites and
tumor cells have poor tolerance to heat compared to normal healthy cells and are easily killed
with near infrared saunas.
LEUKOCELL 2 is a multiple viral antigen vaccine for vaccination of healthy cats 9 weeks of age or older as an aid in preventing persistent viremia, lymphoid
tumors caused by feline leukemia
virus (FeLV) and diseases associated
with FeLV infection.
A beautiful, thick blue oil - Blue Cypress is reported to have wonderful promise in use
with viruses, warts,
tumors and more.
Neurosurgeons from the University of Alabama at Birmingham are partnering
with veterinary universities to conduct the first immunotherapy study for brain
tumors in dogs using an oncolytic herpes simplex
virus.
The University of Alabama at Birmingham (UAB) is partnering
with veterinary universities to conduct the first immunotherapy study for brain
tumors in dogs using an oncolytic herpes simplex
virus known as M032.
Dogs
with any cancer (except hemangiosarcoma and mast cell
tumor) might be eligible for a clinical trial to define the optimal dose and schedule for an oncolytic
virus treatment (VSV - IFNβ - NIS).